Terry Evans

Low Overexpression of HER-2/Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

Ramesh K. Ramanathan, Jimmy J. Hwang, William C. Zamboni et al. · Cancer Investigation · 2004 · 137 citations

Phase II Trial of Short-Course CHOP-R Followed by 90Y-ibritumomab Tiuxetan and Extended Rituximab in Previously Untreated Follicular Lymphoma

Samuel A. Jacobs, Steven H. Swerdlow, Jeffrey A. Kant et al. · Clinical Cancer Research · 2008 · 90 citations · Full text

Dual Inhibition of the Epidermal Growth Factor Receptor with Cetuximab, an IgG1 Monoclonal Antibody, and Gefitinib, A Tyrosine Kinase Inhibitor, in Patients with Refractory Non-small Cell Lung Cancer (NSCLC): A Phase I Study

Suresh S. Ramalingam, Judy Forster, C Naret et al. · Journal of Thoracic Oncology · 2008 · 51 citations · Full text

Dual Inhibition, Medicine, Immunology +8

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E1697)

Sanjiv S. Agarwala, Sandra J. Lee, Wai‐Ki Yip et al. · Journal of Clinical Oncology · 2017 · 45 citations

Randomized Trial of Influenza Vaccine With Granulocyte-Macrophage Colony-Stimulating Factor or Placebo in Cancer Patients

Ramesh K. Ramanathan, Douglas M. Potter, Chandra P. Belani et al. · Journal of Clinical Oncology · 2002 · 37 citations